NCT06230393Terminated
An Extension Trial for Patients With Open-Angle Glaucoma Who Participated in the DF6-CL-20-01 Protocol.
An Extension Trial to Evaluate the Long Term Safety and Effectiveness of the STREAMLINE® SURGICAL SYSTEM in Patients With Open-Angle Glaucoma Who Participated in the DF6-CL-20-01 Protocol.
Source: ClinicalTrials.gov · Last updated 30 Mar 2026
Brief summary (registry, in English)
The purpose of this study is to evaluate long term safety and effectiveness of the STREAMLINE® SURGICAL SYSTEM
- Status (registry)
- Terminated
- Study type
- Observational
- Enrollment
- 17 (actual)
- First submitted
- 19 Jan 2024
- Start date
- 1 Jun 2024
- Primary completion date
- 4 Dec 2025
- Lead sponsor
- New World Medical, Inc.
- Diseases
- Glaucoma
- NCT number
- NCT06230393
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- lost to follow up in the DF6-CL-20-01 trial
Who the study is looking for
- participated in the DF6-CL-20-01 trial.
Sex: All
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Clínica 20/20 Coordinator of this site? Confirm its status | San José | Costa Rica | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.